NatWest Group plc - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
NatWest Group plc ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2014$973,000
+10.7%
91,856
+23.8%
0.01%
-78.4%
Q2 2014$879,000
-14.6%
74,216
+7.7%
0.04%
-19.6%
Q1 2014$1,029,000
+18.3%
68,918
+16.2%
0.05%
+109.1%
Q4 2013$870,000
-4.9%
59,292
+10.3%
0.02%
-18.5%
Q3 2013$915,000
-10.3%
53,763
-12.6%
0.03%
+92.9%
Q2 2013$1,020,00061,4850.01%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 10,906,962$69,914,0003.04%
Fernwood Investment Management, LLC 224,500$1,439,0000.77%
Telemetry Investments, L.L.C. 272,000$1,744,0000.66%
Schonfeld Strategic Advisors LLC 865,356$5,547,0000.45%
Virtus ETF Advisers LLC 53,977$346,0000.43%
Endurant Capital Management LP 210,800$1,351,0000.41%
SPHERA FUNDS MANAGEMENT LTD. 500,000$3,205,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$726,0000.37%
Orbimed Advisors 2,834,126$18,167,0000.23%
PINNACLE ASSOCIATES LTD 1,322,231$8,476,0000.16%
View complete list of IMMUNOGEN INC shareholders